Rights and permissions
About this article
Cite this article
Natalizumab affirms QOL improvement in MS. Pharmacoecon. Outcomes News 502, 9 (2006). https://doi.org/10.2165/00151234-200605020-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605020-00023